Status:
COMPLETED
Fatty Liver and Ectopic Fat in Overweight and Obese Patients
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Steatohepatitis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The aim of the study is to find new clinico-biological and medical imaging parameters associated with non alcoholic steatohepatitis in overweight and obese patients.
Detailed Description
Non invasive assessment of liver fibrosis and liver inflammation and steatosis is clinically relevant in patients exposed to non alcoholic fatty liver diseases. The aim of the study is to find new cl...
Eligibility Criteria
Inclusion
- BMI between 25 and 40
- ALAT level superior to normal level even after 3 months of diet
- alcohol consumption \< 20 g/j for women and \< 30 g/j for men
Exclusion
- HIV, hepatitis B virus, hepatitis C virus positive
- known hemochromatosis
- glycemia \> 1.26 g/L or under anti-diabetic treatment
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 2 2014
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00886301
Start Date
March 1 2010
End Date
October 2 2014
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hepatogastroenterology, Hôpital l'Archet, CHU de Nice
Nice, France, 06000